Clinigen and Santhera Launch US Expanded Access Program with Idebenone for Patients with …

EAPs such as BreatheDMD allow eligible patients with serious or life-threatening conditions to access an investigational medicinal product, upon physician request, before it is approved by regulatory authorities where there is no suitable alternative treatment for the medical condition. Idebenone is a …
Go to Source